Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancerClaire Fletcher, Charlotte L. Bevan|Oncogene|2019Cited by 70
Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumoursD. Alwyn Dart, Charlotte L. Bevan|Endocrine Related Cancer|2009Cited by 56
The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancerTheodora A. Constantin, Charlotte L. Bevan|British Journal of Cancer|2023Cited by 24